RecruitingNCT04025515

Molecular Profiling Project

ATORG001 - Molecular Profiling Project


Sponsor

National Cancer Centre, Singapore

Enrollment

500 participants

Start Date

Jan 11, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

In this study, the investigators plan to undertake comprehensive molecular profiling of "actionable" alterations in lung cancer specimens in order to determine the prevalence of each genetic subtype in the local population.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is performing detailed molecular profiling — analyzing the genetic and molecular makeup — of tumor samples from cancer patients to identify potential targets for clinical trials and personalized treatment strategies. **You may be eligible if...** - You are 21 or older - You have enough stored tumor tissue available for molecular testing (at least 15 slides) - You are in adequate health overall (WHO performance status ≤ 2, life expectancy ≥ 12 weeks) - Your blood counts, liver function, and other organ tests meet minimum thresholds - You are willing to provide signed informed consent **You may NOT be eligible if...** - There is insufficient tumor tissue for testing - You are too unwell to potentially participate in future clinical trials - You have conditions that compromise your organ function to a degree that would exclude you from most trials Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(10)

The Brunei Cancer Centre

Brunei, Brunei

Hong Kong Integrated Oncology Centre

Hong Kong, Hong Kong

The Chinese University of Hong Kong, Department of Clinical Oncology

Hong Kong, Hong Kong

Rajiv Ghandhi Cancer Institute and Research Centre

New Delhi, India

Penang Adventist Hospital

George Town, Malaysia

Pantai Hospital, Kuala Lumpur

Kuala Lumpur, Malaysia

University Malaya Medical Centre, Clinical Oncology Department

Kuala Lumpur, Malaysia

Beacon Hospital

Petaling Jaya, Malaysia

National Cancer Centre Singapore

Singapore, Singapore

Phramongkutklao Hospital

Bangkok, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04025515


Related Trials